• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    CEO and Chairman Allison R Dirk was granted 63,500 shares, increasing direct ownership by 62% to 166,461 units (SEC Form 4)

    3/12/25 4:00:05 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care
    Get the next $ADUS alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    ALLISON R DIRK

    (Last) (First) (Middle)
    6303 COWBOYS WAY
    SUITE 600

    (Street)
    FRISCO TX 75034

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Addus HomeCare Corp [ ADUS ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    X Officer (give title below) Other (specify below)
    CEO and Chairman
    3. Date of Earliest Transaction (Month/Day/Year)
    03/10/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 03/10/2025 A 63,500(1) A $0 166,461 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. The shares will vest in full on the third anniversary on March 10, 2028, subject to customary provisions for continued service and acceleration on certain previously disclosed conditions.
    /s/ Brian Poff, Attorney-in-Fact for R. Dirk Allison 03/12/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $ADUS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ADUS

    DatePrice TargetRatingAnalyst
    12/16/2024$150.00Mkt Outperform
    JMP Securities
    10/11/2024$150.00Overweight
    KeyBanc Capital Markets
    6/28/2024$136.00Outperform
    Macquarie
    4/23/2024$83.00Equal Weight → Underweight
    Barclays
    3/6/2024$88.00Equal Weight
    Barclays
    2/5/2024Outperform
    William Blair
    12/12/2023$105.00Outperform
    TD Cowen
    6/29/2022$101.00Buy
    Stifel
    More analyst ratings

    $ADUS
    SEC Filings

    See more
    • SEC Form 10-Q filed by Addus HomeCare Corporation

      10-Q - Addus HomeCare Corp (0001468328) (Filer)

      5/6/25 4:30:26 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • SEC Form 8-K filed by Addus HomeCare Corporation

      8-K - Addus HomeCare Corp (0001468328) (Filer)

      5/5/25 4:54:55 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Addus HomeCare Corporation filed SEC Form 8-K: Leadership Update

      8-K - Addus HomeCare Corp (0001468328) (Filer)

      3/11/25 4:12:41 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care

    $ADUS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • JMP Securities initiated coverage on Addus HomeCare with a new price target

      JMP Securities initiated coverage of Addus HomeCare with a rating of Mkt Outperform and set a new price target of $150.00

      12/16/24 6:21:27 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • KeyBanc Capital Markets initiated coverage on Addus HomeCare with a new price target

      KeyBanc Capital Markets initiated coverage of Addus HomeCare with a rating of Overweight and set a new price target of $150.00

      10/11/24 7:29:16 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Macquarie initiated coverage on Addus HomeCare with a new price target

      Macquarie initiated coverage of Addus HomeCare with a rating of Outperform and set a new price target of $136.00

      6/28/24 7:30:03 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care

    $ADUS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Addus HomeCare Corporation

      SC 13G - Addus HomeCare Corp (0001468328) (Subject)

      11/13/24 9:44:25 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Addus HomeCare Corporation (Amendment)

      SC 13G/A - Addus HomeCare Corp (0001468328) (Subject)

      2/13/24 4:55:59 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Addus HomeCare Corporation (Amendment)

      SC 13G/A - Addus HomeCare Corp (0001468328) (Subject)

      1/22/24 2:03:09 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care

    $ADUS
    Leadership Updates

    Live Leadership Updates

    See more
    • Axonics® Announces Appointment of Dr. Esteban López to its Board of Directors

      Axonics, Inc. (NASDAQ:AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced the appointment of Esteban López, M.D., MBA, to its board of directors, effective immediately. "Axonics is fortunate to have someone of Dr. López's character and extensive experience join our board of directors," said Raymond W. Cohen, CEO of Axonics. "Given his thought leadership in healthcare, Dr. López will be a valuable adviser to Axonics as we continue to execute on our ambitious growth objectives." Dr. López is the Americas healthcare and life sciences Market Lead at Google Cloud with multinational

      7/15/21 6:00:00 AM ET
      $AXNX
      $ADUS
      Medical/Dental Instruments
      Health Care
      Medical/Nursing Services
    • Addus HomeCare Announces Retirement of Laurie Manning

      Robby Stevenson Named Company's Chief Human Resource Officer Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, announced today that Laurie Manning retired from her position as Executive Vice President and Chief Human Resource Officer, effective June 11, 2021. Robby Stevenson, Senior Vice President of Human Resources, has been promoted to Executive Vice President and Chief Human Resource Officer and will assume leadership in that area. Commenting on the announcement, Dirk Allison, Chairman and Chief Executive Officer, said, "Laurie has played an important role in the growth and success of Addus since she joined the Company in 2017. Our employees are our most impor

      6/14/21 8:00:00 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Addus HomeCare Names Veronica Hill-Milbourne And Esteban López, M.D. To Board Of Directors

      FRISCO, Texas, Jan. 11, 2021 /PRNewswire/ -- Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced that Veronica Hill-Milbourne and Esteban López, M.D. have been appointed to the Company's Board of Directors, effective January 11, 2021. Ms. Hill-Milbourne is President and Chief Executive Officer of Spectrum Health Services, Inc., with executive oversight of three Federally Qualified Health Centers located in Philadelphia, Pennsylvania. She previously served as Chief Executive Officer/State Director for Pathways by Atar Capital, with executive oversight of mental and behavioral health home and community-based service programs operating in 30 counties

      1/11/21 8:00:00 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care

    $ADUS
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $ADUS
    Financials

    Live finance-specific insights

    See more
    • Addus HomeCare to Participate in Upcoming Investor Conferences in May

      Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its participation at the following investor conferences in May: BofA Securities 2025 Health Care Conference in Las Vegas, Nevada, on Wednesday, May 14, 2025. Dirk Allison, Chairman and Chief Executive Officer, Brad Bickham, President and Chief Operating Officer, and Brian Poff, Executive Vice President and Chief Financial Officer, will present at 9:20 a.m. Pacific Time / 11:20 a.m. Central Time on Wednesday, May 14, 2025. 2025 RBC Capital Markets Global Healthcare Conference in New York on Tuesday, May 20, 2025. Dirk Allison, Chairman and Chief Executive Officer and Brian Poff, Executive Vice Pr

      5/6/25 11:00:00 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Addus HomeCare Announces First Quarter 2025 Financial Results

      Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights: Net Service Revenues Grow 20.3% to $337.7 Million Net Income of $21.2 Million, or $1.16 per Diluted Share Adjusted Net Income per Diluted Share Increases 17.4% year-over-year to $1.42 Adjusted EBITDA Increases 25.1% year-over-year to $40.6 Million Cash Flow from Operations of $18.9 Million Overview Net service revenues were $337.7 million for the first quarter of 2025, a 20.3% increase compared with $280.7 million for the first quarter of 2024. Net income was $21.2 million for the first quar

      5/5/25 4:05:00 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Addus HomeCare Announces First Quarter 2025 Earnings Release and Conference Call

      Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, announced today that it will release earnings for the first quarter ended March 31, 2025, on Monday, May 5, 2025, after the market close. Addus HomeCare will host a conference call on Tuesday, May 6, 2025, at 9:00 a.m. Eastern Time. Joining the call from the Company will be Dirk Allison, Chairman and CEO, Brian Poff, Executive Vice President and CFO, and Brad Bickham, President and COO. To access the live call, dial (833) 629-0620 (international dial-in number is (412) 317-1805) and ask to join the Addus HomeCare earnings call. A telephonic replay of the conference call will be available through midnight on May 13,

      4/21/25 11:00:00 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Addus HomeCare Announces First Quarter 2025 Financial Results

      Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights: Net Service Revenues Grow 20.3% to $337.7 Million Net Income of $21.2 Million, or $1.16 per Diluted Share Adjusted Net Income per Diluted Share Increases 17.4% year-over-year to $1.42 Adjusted EBITDA Increases 25.1% year-over-year to $40.6 Million Cash Flow from Operations of $18.9 Million Overview Net service revenues were $337.7 million for the first quarter of 2025, a 20.3% increase compared with $280.7 million for the first quarter of 2024. Net income was $21.2 million for the first quar

      5/5/25 4:05:00 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Addus HomeCare Announces First Quarter 2025 Earnings Release and Conference Call

      Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, announced today that it will release earnings for the first quarter ended March 31, 2025, on Monday, May 5, 2025, after the market close. Addus HomeCare will host a conference call on Tuesday, May 6, 2025, at 9:00 a.m. Eastern Time. Joining the call from the Company will be Dirk Allison, Chairman and CEO, Brian Poff, Executive Vice President and CFO, and Brad Bickham, President and COO. To access the live call, dial (833) 629-0620 (international dial-in number is (412) 317-1805) and ask to join the Addus HomeCare earnings call. A telephonic replay of the conference call will be available through midnight on May 13,

      4/21/25 11:00:00 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Addus HomeCare Announces Fourth Quarter and Year End 2024 Financial Results

      Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its financial results for the fourth quarter and year ended December 31, 2024. Fourth Quarter 2024 Highlights: Net Service Revenues Grow 7.5% to $297.1 Million Net Income of $19.5 Million, or $1.07 per Diluted Share Adjusted Net Income per Diluted Share Increases 4.6% year-over-year to $1.38 Adjusted EBITDA Increases 10.3% year-over-year to $37.8 Million Cash Flow from Operations of $10.4 Million Completed acquisition of Gentiva personal care operations Overview Net service revenues were $297.1 million for the fourth quarter of 2024, a 7.5% increase compared with $276.4 milli

      2/24/25 4:05:00 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care

    $ADUS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • EVP/Chief Development Officer Blessing Cliff Donald sold $18,008 worth of shares (178 units at $101.17), decreasing direct ownership by 2% to 10,401 units (SEC Form 4)

      4 - Addus HomeCare Corp (0001468328) (Issuer)

      4/22/25 4:30:22 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • EVP/Chief Financial Officer Poff Brian was granted 31,750 shares, increasing direct ownership by 96% to 64,719 units (SEC Form 4)

      4 - Addus HomeCare Corp (0001468328) (Issuer)

      3/12/25 4:00:12 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • CEO and Chairman Allison R Dirk was granted 63,500 shares, increasing direct ownership by 62% to 166,461 units (SEC Form 4)

      4 - Addus HomeCare Corp (0001468328) (Issuer)

      3/12/25 4:00:05 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care